Subscribe to Breaking News emails

You have successfully subscribed to the Breaking News email.

Subscribe today to be the first to to know about breaking news and special reports.

Lawyer Says Turing Execs Warned Shkreli Against Drug Price Hike

/ Source: Associated Press

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.

The former top lawyer for Turing Pharmaceuticals says he and other executives warned Martin Shkreli against the drastic price hike that triggered a national backlash against the company and its 32-year-old CEO.

Turing's former general counsel will tell Senate lawmakers that the fiftyfold price increase on Daraprim, a drug used to treat life-threatening parasitic infections, "was not justified," according to prepared remarks obtained by The Associated Press.

Howard Dorfman, who left Turing last August, will state that he and other staffers objected to the hike because it would have "a severely negative impact on Turing's business and reputation."

The Senate Aging Committee is scheduled to hear from current and former Turing executives. Shkreli, who is facing criminal charges in New York unrelated to Turing, is not scheduled to appear.

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.
MORE FROM news